Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions

Journal of Cardiovascular Electrophysiology

Volumn 3, Issue 1, 1992, Pages 2-16

  SCHWARTZ, PETER J ^a,b   MOTOLESE, MARIO ^c   POLLAVINI, GIORGIO ^c   LOTTO, ANTONIO ^d   RUBERTI, UGO ^b   TRAZZI, RINALDO ^b   BARTORELLI, CESARE ^b   ZANCHETTI, ALBERTO ^b   GROUP, THE ITALIAN SUDDEN DEATH PREVENTION ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NOVARTIS PHARMA AG   (Switzerland)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

clinical trials; left sympathectomy; sympathetic nervous system; adrenergic mechanisms; adrenergic blockade

Indexed keywords

OXPRENOLOL;

ADRENERGIC TRANSMISSION; ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED STUDY; DENERVATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREVENTION; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SYMPATHECTOMY;

EID: 0026558884     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1992.tb01090.x     Document Type: Article

References (59)

1. Sudden, cardiac death: The major challenge confronting contemporary cardiology
2. Neural mechanisms in life‐threatening arrhythmias
3. The role of the autonomic nervous system in sudden coronary death
4. Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis
5. Cardiac electrophysiology: Promises and contributions
6. Sympathetic nervous system and cardiac arrhythmias
7. Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion
8. Behavioural stress and cardiac arrhythmias
9. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction
10. The induction of arrhythmias by sympathetic activity before and after occlusion of a coronary artery in the canine heart
11. A new experimental model for the study of cardiac arrhythmias dependent on the interaction between acute myocardial ischemia and sympathetic hyperactivity
12. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death
13. A sympathetic reflex elicited by experimental coronary occlusion
14. Global versus regional myocardial ischaemia: Differences in cardiovascular and sympathetic responses in cats
15. Effect of dorsal root section on the arrhythmias associated with coronary occlusion
16. Effect on mortality of metoprol in acute myocardial infarction. A double‐blind randomised trial
17. Timolol‐induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
18. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
19. Beta‐blocker effectiveness post infarction: An antiarrhythmic or antiischemic effect
20. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias
21. The idiopathic long QT syndrome: Progress and questions
22. Excessive five years mortality of anterior myocardial infarction complicated by ventricular fibrillation
23. Effect of ventricular fibrillation complicating acute myocardiaJ infarction on long‐term prognosis: Importance of the site of infarction
24. Surgical and pharmacological antiadrenergic interventions in the prevention of sudden death after a first myocardial infarction
25. Survivorship patterns in the posthospital phase of myocardial infarction
26. Quantification of oxprenoiol in biological fluids using high performance liquid chromatography
27. Sample sizes for medical trials with special reference to long‐term therapy
28. Non parametric estimation from incomplete observations
29. Evaluation of survival data and two new rank order statistics arising in its consideration
30. Sympathetic imbalance and cardiac arrhythmias
31. Dispersion of refractoriness in canine ventricular myocardium
32. Flow of “injury” current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts: Evidence for two different arrhythmogenic mechanisms
33. Differential response to right and left ansae subclaviae stimulation of early afterdepolarizations and ventricular tachycardia induced by cesium in dogs
34. Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation
35. Effects of alpha adrenergic stimulation and blockade on early afterdepolarizations induced by cesium in canine cardiac Purkinje fibers
36. Effects of unilateral stellate sympathetic denervation on the ventricular fibrillation threshold
37. Effect of stellectomy and vagotomy on ventricular refractoriness
38. Effect of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion
39. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction
40. Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution
41. Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs
42. Unilateral stellectomy and infarct size
43. Left stellectomy and denervation supersensitivity in conscious dogs
44. Effects of unilateral stellectomy upon cardiac performance during exercise in dogs
45. Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: A world‐wide report
46. Risk stratification and survival after myocardial infarction
47. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
48. Late clinical outcome in patients with early ventricular fibrillation after myocardial infarction
49. One‐year prognosis of primary ventricular fibrillation complicating acute myocardiai infarction
50. Prognostic significance of location and type of myocardial infarction: Independent adverse outcome associated with anterior location
51. Partial agonist activity of beta‐blocking agents and cardiac performance: A review
52. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta‐adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanisms
53. Intrinsic sympathomimetic activity: Clinical fact or fiction
54. Controlled trial of sotalol for one year after myocardial infarction
55. A secondary prevention study with slow release oxprenolol after myocardial infarction: Morbidity and mortality
56. A long‐term prevention study with oxprenolol in coronary heart disease